StockSelector.com
  Research, Select, & Monitor Friday, September 21, 2018 1:13:42 PM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
Incyte Corp.$67.76($.52)(.76%)

  Quote | Ranking | Chart | Valuations | Sentiment | News | Earnings | Analysts | More...

Your Target?

  Incyte Corp. vs Biotechnology

Incyte Corp is a drug discovery company that is using its expertise in genomics, medicinal chemistry and molecular, cellular and in vivo biology to discover and develop novel therapeutics. The company has three fully-staffed drug discovery programs underway focused primarily on the identification of new small molecule drugs for cancer and inflammation. Incyte also has strategic alliances with Lexicon Genetics and Medarex focused on the discovery and development of protein therapeutics or antibodies to treat inflammatory diseases and cancer.




An exciting industry consisting of companies who develop new drugs to combat such diseases as cancer and other life-threatening diseases. Some may also participate in gene therapy. These firms either bring new drugs to the market themselves (which is a grueling process) or they sell their technology to bigger pharmaceutical companies.
 Totals Company Industry
  Sales: $1,536.2 Mil $93,638.6 Mil
  Market Cap: $14,687.2 Mil $517,358.5 Mil
  Analysts Recommendation: Buy Buy

 Averages Company Industry
 Growth
  Historic Revenue: 38.9% 42.3%
  Estimated Revenue: 15.2% 104.1%
  Historic Earnings: 4.9% (35.9%)
  Estimated Earnings: 101.6% 7.7%
  Stock Price (1 Year): (40.6%) 46.1%
  Cash per Share: 23.1% 17.4%
  Dividend: N/A N/A
 Price
  Trailing PE: N/A N/A
  Forward PE: 35.2 30.3
  Price-to-Sales: 8.5 N/A
  Price-to-Book: 8.8 4.7
  Dividend Yield: N/A N/A
  Market Cap: $14,687.2 Mil $11,246.9 Mil
  Operations
  Net Margin: 1.7% (1,230.9%)
  Gross Margin: 94.8% 75.5%
  Return on Equity: (.2) (.3)
  Return on Assets: (.1) (.3)
  Balance Sheet
  Current Ratio: 4.0 5.0
  Quick Ratio: 4.0 4.6
  Cash Ratio: 3.1 3.9
  Debt-to-Equity: .4 1.0
  Interest Coverage: (8.9) 1.7
 Technicals
  Relative-Strength Index: 52.7 46.1

 Other companies in Biotechnology Price Market Cap
  Amgen, Inc.  (AMGN) $205.10 $135,366.0 Mil
  Gilead Sciences, Inc.  (GILD) $74.83 $97,877.6 Mil
  Biogen Inc.  (BIIB) $341.24 $70,739.1 Mil
  Celgene Corp.  (CELG) $88.30 $64,688.6 Mil
  Regeneron Pharmaceuticals Inc.  (REGN) $387.25 $44,331.2 Mil






Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2018 StockSelector.com. All rights reserved.